Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12616001114437p
Ethics application status
Submitted, not yet approved
Date submitted
14/08/2016
Date registered
17/08/2016
Date last updated
27/11/2019
Date data sharing statement initially provided
27/11/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Analysing and Using Demographic Information and Treatment Endpoints to Determine Numbers (AUDITED Numbers) for The Sildenafil during Coronary artery bypass graft Operations to Reduce Endpoints for patients with Coronary ARtery Disease (SCORECARD) Project
Query!
Scientific title
Analysing and Using Demographic Information and Treatment Endpoints to Determine Numbers (AUDITED Numbers) for The Sildenafil during Coronary artery bypass graft Operations to Reduce Endpoints for patients with Coronary ARtery Disease (SCORECARD) Project
Query!
Secondary ID [1]
289931
0
None
Query!
Universal Trial Number (UTN)
U1111-1186-4611
Query!
Trial acronym
AUDITED Numbers
Query!
Linked study record
There is currently no ACTRN number for the linked SCORECARD Project record. AUDITED Numbers will help define the population size and the occurrence rate of short-term outcomes for a future Phase II study, both of which are two components of the five-arm SCORECARD Project.
Query!
Health condition
Health condition(s) or problem(s) studied:
Coronary artery disease
299904
0
Query!
Condition category
Condition code
Cardiovascular
299806
299806
0
0
Query!
Coronary heart disease
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Retrospective analysis of the clinical notes of all patients who underwent coronary artery bypass graft surgery at Greenlane Cardiothoracic Surgical Unit between 1 August 2015 and 31 July 2016.
Query!
Intervention code [1]
295612
0
Not applicable
Query!
Comparator / control treatment
Not applicable.
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
299279
0
Diagnosed myocardial infarction based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Assessment method [1]
299279
0
Query!
Timepoint [1]
299279
0
Within 30 days post-coronary artery bypass graft surgery
Query!
Secondary outcome [1]
326709
0
Diagnosed vasospasm based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Assessment method [1]
326709
0
Query!
Timepoint [1]
326709
0
Within 30 days post-coronary artery bypass graft surgery based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Secondary outcome [2]
326710
0
Diagnosed graft failure based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Assessment method [2]
326710
0
Query!
Timepoint [2]
326710
0
Within 30 days post-coronary artery bypass graft surgery
Query!
Secondary outcome [3]
326711
0
Mortality-rate
Query!
Assessment method [3]
326711
0
Query!
Timepoint [3]
326711
0
At 30 days post-coronary artery bypass graft surgery
Query!
Secondary outcome [4]
326712
0
Diagnosed acute kidney injury based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Assessment method [4]
326712
0
Query!
Timepoint [4]
326712
0
Within 30 days post-coronary artery bypass graft surgery
Query!
Secondary outcome [5]
326713
0
Repeat revascularisation procedure based upon review of the patient's anaesthetic record, Cardiovascular Intensive Care Unit record and discharge summary from the cardiothoracic service.
Query!
Assessment method [5]
326713
0
Query!
Timepoint [5]
326713
0
Within 30 days post-coronary artery bypass graft surgery
Query!
Secondary outcome [6]
326714
0
Duration of intubation based upon review of the patient's anaesthetic record and Cardiovascular Intensive Care Unit record.
Query!
Assessment method [6]
326714
0
Query!
Timepoint [6]
326714
0
At time of extubation
Query!
Secondary outcome [7]
326715
0
Duration of Cardiovascular Intensive Care Unit stay based upon review of the patient's Cardiovascular Intensive Care Unit record.
Query!
Assessment method [7]
326715
0
Query!
Timepoint [7]
326715
0
Time of discharge from Cardiovascular Intensive Care Unit
Query!
Secondary outcome [8]
326716
0
Duration of admission based upon review of the patient's discharge summary from the cardiothoracic service.
Query!
Assessment method [8]
326716
0
Query!
Timepoint [8]
326716
0
Time of discharge from hospital
Query!
Eligibility
Key inclusion criteria
1) Underwent coronary artery bypass graft surgery.
2) Procedure between 1 August 2015 and 31 July 2016.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
None
Query!
Study design
Purpose
Screening
Query!
Duration
Cross-sectional
Query!
Selection
Defined population
Query!
Timing
Retrospective
Query!
Statistical methods / analysis
This retrospective analysis of all patients undergoing coronary artery bypass graft surgery at Greenlane Cardiothoracic Surgical Unit within a 12-month period will provide a snapshot of the mean intraoperative and postoperative characteristics of patients such as the average duration of intubation. This analysis will also provide a snapshot of the short-term (30 days) morbidity- and mortality-rates of coronary artery bypass graft surgery patients.
Query!
Recruitment
Recruitment status
Withdrawn
Query!
Reason for early stopping/withdrawal
Other reasons/comments
Query!
Other reasons
Elected to withdraw study.
Query!
Date of first participant enrolment
Anticipated
1/09/2016
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
28/10/2016
Query!
Actual
Query!
Date of last data collection
Anticipated
28/10/2016
Query!
Actual
Query!
Sample size
Target
250
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
8098
0
New Zealand
Query!
State/province [1]
8098
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
294304
0
University
Query!
Name [1]
294304
0
University of Auckland
Query!
Address [1]
294304
0
Department of Anaesthesiology
University of Auckland
Private Bag 92019
Auckland 1142
Query!
Country [1]
294304
0
New Zealand
Query!
Primary sponsor type
University
Query!
Name
University of Auckland
Query!
Address
Department of Anaesthesiology
University of Auckland
Private Bag 92019
Auckland 1142
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
293144
0
None
Query!
Name [1]
293144
0
Query!
Address [1]
293144
0
Query!
Country [1]
293144
0
Query!
Ethics approval
Ethics application status
Submitted, not yet approved
Query!
Ethics committee name [1]
295731
0
Health and Disability Ethics Committee
Query!
Ethics committee address [1]
295731
0
Ministry of Health Ethics Department Freyberg Building Reception – Ground Floor 20 Aitken Street Wellington 6011
Query!
Ethics committee country [1]
295731
0
New Zealand
Query!
Date submitted for ethics approval [1]
295731
0
27/07/2016
Query!
Approval date [1]
295731
0
Query!
Ethics approval number [1]
295731
0
Query!
Summary
Brief summary
Rationale of Study As described in detail elsewhere, cardiovascular disease is the greatest cause of mortality in New Zealand. Coronary artery disease (CAD) is not only implicated in most of these patients but is also the commonest cause of death, worldwide. In patients with severe CAD, the gold-standard revascularisation approach is CABG which, in low-risk patients, carries a mortality risk of < 1%. Furthermore, the success-rates of CABG have increased substantially over the last several decades as a result of improvements in surgical technique and the development of an increasingly robust literature-base. However, major adverse cardiac events still affect around 5% of patients and they are potently associated with the incidence of vasospasm, graft occlusion and ischaemia-reperfusion injury. Therefore, the continued development and refinement of methods to reduce these complications has the potential to significantly improve CABG outcomes. A variety of techniques are presently employed to reduce vasospasm and graft occlusion. For example, the use of the ‘no-touch’ technique during graft harvesting significantly reduces vasospasm and the intraluminal administration of a nitroglycerin-verapamil solution reduces the risk of graft occlusion. However, these approaches are not foolproof. Every graft requires at least some degree of physical contact during anastomosis and the nitroglycerin-verapamil solution is limited by its short half-life and marked systemic effects. Ischaemia-reperfusion injury is also a relatively new concept and, while clinical studies investigating the therapeutic effect of remote ischaemic preconditioning have been successful, routine use in the operating theatre remains scarce. Sildenafil is a type 5 phosphodiesterase inhibitor that has vasodilatory, antiplatelet and ischaemia-reperfusion injury-preventing properties. Thus, it has been suggested that sildenafil might have novel therapeutic effects in patients undergoing CABG. A double-blind randomised controlled trial is currently being designed in order to investigate this hypothesis. However, it is unknown exactly what proportion of patients undergoing CABG within the Auckland region suffer from short-term vasospasm, graft occlusion and ischaemia-reperfusion injury or which demographic groups are over-represented in patients undergoing CABG. Therefore, the purpose of this study is to determine the demographic makeup and vasospasm, graft occlusion and ischaemia reperfusion-injury complication-rates in patients undergoing CABG within the greater Auckland region.
Query!
Trial website
None
Query!
Trial related presentations / publications
None
Query!
Public notes
None
Query!
Contacts
Principal investigator
Name
68246
0
Dr Steve Waqanivavalagi
Query!
Address
68246
0
Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1142
Query!
Country
68246
0
New Zealand
Query!
Phone
68246
0
+64275370425
Query!
Fax
68246
0
Query!
Email
68246
0
[email protected]
Query!
Contact person for public queries
Name
68247
0
Steve Waqanivavalagi
Query!
Address
68247
0
Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1142
Query!
Country
68247
0
New Zealand
Query!
Phone
68247
0
+64275370425
Query!
Fax
68247
0
Query!
Email
68247
0
[email protected]
Query!
Contact person for scientific queries
Name
68248
0
Steve Waqanivavalagi
Query!
Address
68248
0
Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1142
Query!
Country
68248
0
New Zealand
Query!
Phone
68248
0
+64275370425
Query!
Fax
68248
0
Query!
Email
68248
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF